Med Center Health is the first hospital in the region, and the seventh in the state, to offer a new treatment for patients ...

Researchers at Fred Hutch Cancer Center have identified a previously overlooked molecular regulator that helps determine ...

A new study by the Medical University of Vienna found that a specialized form of imaging could identify 91% of prostate cancer cases without the need for a biopsy. Traditionally, a blood test can ...

A single tRNA can influence whether prostate cancer cells mutate and become difficult to treat with standard therapies.

The Metastatic Prostate Cancer clinical trial analysis report delivers important insights into ongoing research of 80+ ...

Researchers at Fred Hutch Cancer Center have identified a previously overlooked molecular regulator that helps determine ...

Thousands of men with prostate cancer could avoid the debilitating urinary and sexual side effects of surgery, thanks to a ...

A new treatment approved by the FDA in June is giving certain men with advanced prostate cancer another treatment option.

Five-treatment stereotactic body radiation therapy (SBRT) provided excellent long-term cancer control with fewer urinary and ...

A new study revealed molecular features linked to more aggressive prostate cancer in a subset of patients who had been ...

At Fox Chase Cancer Center, specialists consider PSA levels, biopsy results, imaging, risk group, overall health, and personal priorities when helping patients choose a course of care.

UCLA investigators present the latest radiotherapy research at the American Society for Radiation Oncology annual meeting ...